
Mick Riley discusses the challenges and strategies of spinning out plant cell IP from a university into a successful biotech startup.
Episode 92: Forever Harvest: Mick Riley on spinning Plant Cell IP out of the university and the B2C trap In this episode, I sit down with Mick Riley, Co-founder and CEO of Forever Harvest, a New Zealand-based plant cell culture startup that recently closed a $1.2M pre-seed round. Mick details how he stepped in as the commercial CEO to spin out "high seven-figure" IP from a public research institute, taking raw lab science and turning it into a commercial biotech platform. We discuss why growing commodity nuts in a bioreactor makes zero economic sense, and how their strategy shifted to accelerating high-value traits (like Vitamin K2) for corporate B2B partners. 🎧 Listen to the full episode to hear Mick's candid admission about wasting six months trying to build a B2C brand and why pitching themselves as a horizontal platform ultimately secured their VC funding. Key Facts Forever Harvest: Mick Riley: https://www.linkedin.com/in/mick-riley-205a78276/ Website: https://www.foreverharvest.co/ Headquarters: New Zealand Goal : To utilize plant cell culture (growing fruit and nuts "without the tree") to supply FMCGs with highly tailored, premium B2B ingredients, specifically focusing on…
Host: Alex Shandrovsky
Guest: Mick Riley
Organizations: Forever Harvest, Bioeconomy Science Institute, Sprout Agritech
Products: Vitamin K2
Places: New Zealand
Explore listener stats, chart rankings, contacts and more on the Investment Climate podcast page.